Business Standard

India to buy 10 mn doses of Zydus Cadila's Covid vaccine at Rs 265 per dose

The vaccine is administered using a needle-free applicator as opposed to traditional syringes

ZyCov-D
Premium

ZyCov-D

Press Trust of India New Delhi
Drug firm Zydus Cadila on Monday said it has received an order to supply 10 million doses of its COVID-19 vaccine, ZyCoV-D, to the Indian government at Rs 265 per dose.

"Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, the world's first Plasmid DNA Vaccine, to the Government of India at Rs 265 per dose and the needle-free applicator being offered at Rs 93 per dose, excluding GST," the pharma firm said in a regulatory filing

The pricing has been decided in consultation with the central government, it added.

The vaccine will be administered using a needle-free applicator

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in